These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21982548)

  • 1. [Thrombolytic therapy using a low dose of tissue plasminogen activator in children].
    Santiago MJ; López-Herce J; Zarzoso S; Sánchez A; Mencía S; Carrillo A
    An Pediatr (Barc); 2012 Feb; 76(2):77-82. PubMed ID: 21982548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in 13 children: a case series].
    Schermer E; Streif W; Genser N; Frühwirth M; Trawöger R; Simma B
    Wien Klin Wochenschr; 2000 Nov; 112(21):927-33. PubMed ID: 11144008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the outcome of systemic tissue plasminogen activator for the management of venous and arterial thrombosis in pediatrics.
    Newall F; Browne M; Savoia H; Campbell J; Barnes C; Monagle P
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):269-73. PubMed ID: 17414572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of new thrombolytic substances].
    Zeymer U; Neuhaus KL
    Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic therapy in children--clinical experiences with recombinant tissue-plasminogen activator.
    Knöfler R; Dinger J; Kabus M; Müller D; Lauterbach I; Rupprecht E; Taut-Sack H; Weissbach G
    Semin Thromb Hemost; 2001; 27(2):169-74. PubMed ID: 11372772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of tissue plasminogen activator for thrombolysis in occluded peritoneal dialysis catheters in children.
    Shea M; Hmiel SP; Beck AM
    Adv Perit Dial; 2001; 17():249-52. PubMed ID: 11510286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolysis in newborns and infants.
    Nowak-Göttl U; Auberger K; Halimeh S; Junker R; Klinge J; Kreuz WD; Ries M; Schlegel N
    Thromb Haemost; 1999 Sep; 82 Suppl 1():112-6. PubMed ID: 10695499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children.
    Gupta AA; Leaker M; Andrew M; Massicotte P; Liu L; Benson LN; McCrindle BW
    J Pediatr; 2001 Nov; 139(5):682-8. PubMed ID: 11713447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
    Hattenbach LO; Friedrich Arndt C; Lerche R; Scharrer I; Baatz H; Margaron F; Richard G; Behrens-Baumann W; Ohrloff C
    Retina; 2009; 29(7):932-40. PubMed ID: 19584651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue Plasminogen Activator Use in Pediatric Patients: A Single Center Experience.
    Pekpak E; İnce E; Ertem M; Tutar E; İleri T; Ucar T; Tiras ST; Cakmakli HF; Uysal Z
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):e648-e651. PubMed ID: 33480646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombolysis with rt-PA in children with arterial and venous thromboses--a new therapy concept].
    Nowak-Göttl U; Kreuz WD; Schwabe D; Linde R; Kornhuber B
    Klin Padiatr; 1991; 203(5):359-62. PubMed ID: 1942942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA.
    Heeremans JL; Prevost R; Bekkers ME; Los P; Emeis JJ; Kluft C; Crommelin DJ
    Thromb Haemost; 1995 Mar; 73(3):488-94. PubMed ID: 7667833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
    Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK
    Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myocardial infarction during thrombolysis of mechanical aortic valve thrombosis associated with heparin-induced thrombocytopenia.
    Gündüz S; Ozkan M; Biteker M; Duran NE; Güneysu T
    Clin Appl Thromb Hemost; 2011 Jun; 17(3):283-7. PubMed ID: 20460341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-atrial tissue plasminogen activator infusion for prosthetic valve thrombosis.
    Seltzer SM; Reed MD; Siwik ES
    Catheter Cardiovasc Interv; 2006 Jan; 67(1):139-41. PubMed ID: 16345053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful lysis of a mobile left ventricular thrombus by slow infusion of low-dose tissue plasminogen activator].
    Güneş Y; Ceylan Y; Tuncer M
    Turk Kardiyol Dern Ars; 2010 Oct; 38(7):489-91. PubMed ID: 21206203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: a pilot study.
    De Santis A; Moscatelli R; Catalano C; Iannetti A; Gigliotti F; Cristofari F; Trapani S; Attili AF
    Dig Liver Dis; 2010 Jun; 42(6):451-5. PubMed ID: 19819770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.